Three drugmakers are capping out-of-pocket costs for their inhalers. Meanwhile, many digital diabetes management tools aren't all they're cracked up to be.
from US Top News and Analysis https://ift.tt/lQXqd5h
Tuesday, March 26, 2024
CNBC |Healthy Returns: Drugmakers are capping inhaler prices at $35 in a win for some patients
US Top News and Analysis
Tags:
CNBC,
US Top News and Analysis
Subscribe to:
Post Comments (Atom)
Hello, Myself Digital Helping Dose and I am here to contribute some part from my side to the internet. Hope you all will like it.
No comments:
Post a Comment